Open AccessERBB2 in Pediatric Cancer: Innocent Until Proven Guilty
Author(s) -
Gilbertson Richard J.
Publication year - 2005
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.10-7-508
Subject(s) - medicine , cancer , pediatric cancer , pediatric oncology , disease , identification (biology) , childhood cancer , intensive care medicine , pathology , botany , biology
L earning O bjectives After completing this course, the reader will be able to: Review the key aspects of ERBB2 signal biology in normal and cancer cells. Outline available evidence for the involvement of ERBB2 signaling in different pediatric solid cancers. Describe the key challenges associated with translating molecular targeted therapies of adult cancers to pediatric patients.Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com